FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2263402103> ?p ?o ?g. }

• W2263402103 endingPage "640" @default.
• W2263402103 startingPage "633" @default.
• W2263402103 abstract "Intravenous drug users have a high risk of infective endocarditis and reduced survival. Cardiac surgery may be recommended for these patients, but redo surgery is controversial. This study describes the characteristics and outcomes of intravenous drug users accepted for surgery during a 12-year period. This retrospective study included 29 injecting drug users treated with valve surgery for endocarditis between January 2001 and December 2013 at a tertiary academic centre. Survival was assessed by Kaplan–Meier analysis. The median patient age was 36 (24–63) years and 27 patients (93%) were male. Staphylococcus aureus (52%) and Enterococcus faecalis (17%) were the most common microorganisms. Common illicit drugs were opioids (69%), amphetamines (52%) and benzodiazepines (24%). Mixed abuse was reported in 66% of patients. Seven patients (24%) had prior intracardial implants or native valve pathology. Twenty-five patients (86%) were positive for hepatitis C virus antibody, but none carried the human immunodeficiency virus. Twelve (41%) were homeless and 15 (52%) had poor dental hygiene. Three patients (10%) received medication-assisted rehabilitation before surgery. The main indications for surgery were regurgitation and secondary heart failure (86%), embolization (41%) and uncontrolled infection (24%). Aortic valve replacement was performed in 24 patients (83%), either as part of univalvular or multiple valve surgery. Seven patients (24%) had multivalvular endocarditis. All but 3 patients received biological valve prostheses. The 30-day mortality was 7% after first time surgery. During follow-up, 15 patients (52%) presented with reinfection: 10 (35%) were offered a second and 2 (7%) a third operation. Thirty-day mortality was 10% after redo surgery. Thirteen patients (45%) died within a median of 22 (0–84) months. Continued intravenous drug use was reported in 70 and 44% of patients after the first and second operation, respectively. Cardiac surgery for infective endocarditis has acceptable early postoperative results among intravenous drug users. The 2- and 5-year survival were 79 and 59%, respectively. The number of reinfections was high within 2 years, as continued drug use seems to be a major challenge for this group." @default.
• W2263402103 created "2016-06-24" @default.
• W2263402103 creator A5013948118 @default.
• W2263402103 creator A5025688737 @default.
• W2263402103 creator A5034766219 @default.
• W2263402103 creator A5048451258 @default.
• W2263402103 creator A5060104734 @default.
• W2263402103 creator A5060629600 @default.
• W2263402103 date "2016-01-29" @default.
• W2263402103 modified "2023-10-16" @default.
• W2263402103 title "Cardiac surgery for infective endocarditis in patients with intravenous drug use" @default.
• W2263402103 cites W1905008412 @default.
• W2263402103 cites W1907515659 @default.
• W2263402103 cites W1920355337 @default.
• W2263402103 cites W1975930915 @default.
• W2263402103 cites W1982701619 @default.
• W2263402103 cites W1995782517 @default.
• W2263402103 cites W1997903784 @default.
• W2263402103 cites W1999251201 @default.
• W2263402103 cites W2013084267 @default.
• W2263402103 cites W2041175606 @default.
• W2263402103 cites W2088991384 @default.
• W2263402103 cites W2101594898 @default.
• W2263402103 cites W2120778423 @default.
• W2263402103 cites W2124163887 @default.
• W2263402103 cites W2131107562 @default.
• W2263402103 cites W2135173846 @default.
• W2263402103 cites W2141661484 @default.
• W2263402103 cites W2152761988 @default.
• W2263402103 cites W2156451821 @default.
• W2263402103 cites W2157999612 @default.
• W2263402103 cites W2160714410 @default.
• W2263402103 cites W2170104986 @default.
• W2263402103 cites W2171941165 @default.
• W2263402103 cites W2412474453 @default.
• W2263402103 cites W4233377804 @default.
• W2263402103 doi "https://doi.org/10.1093/icvts/ivv397" @default.
• W2263402103 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4892139" @default.
• W2263402103 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26826713" @default.
• W2263402103 hasPublicationYear "2016" @default.
• W2263402103 type Work @default.
• W2263402103 sameAs 2263402103 @default.
• W2263402103 citedByCount "52" @default.
• W2263402103 countsByYear W22634021032017 @default.
• W2263402103 countsByYear W22634021032018 @default.
• W2263402103 countsByYear W22634021032019 @default.
• W2263402103 countsByYear W22634021032020 @default.
• W2263402103 countsByYear W22634021032021 @default.
• W2263402103 countsByYear W22634021032022 @default.
• W2263402103 countsByYear W22634021032023 @default.
• W2263402103 crossrefType "journal-article" @default.
• W2263402103 hasAuthorship W2263402103A5013948118 @default.
• W2263402103 hasAuthorship W2263402103A5025688737 @default.
• W2263402103 hasAuthorship W2263402103A5034766219 @default.
• W2263402103 hasAuthorship W2263402103A5048451258 @default.
• W2263402103 hasAuthorship W2263402103A5060104734 @default.
• W2263402103 hasAuthorship W2263402103A5060629600 @default.
• W2263402103 hasBestOaLocation W22634021031 @default.
• W2263402103 hasConcept C126322002 @default.
• W2263402103 hasConcept C141071460 @default.
• W2263402103 hasConcept C2775872228 @default.
• W2263402103 hasConcept C2778789114 @default.
• W2263402103 hasConcept C2780176578 @default.
• W2263402103 hasConcept C2780727368 @default.
• W2263402103 hasConcept C3013748606 @default.
• W2263402103 hasConcept C3019645122 @default.
• W2263402103 hasConcept C512399662 @default.
• W2263402103 hasConcept C71924100 @default.
• W2263402103 hasConceptScore W2263402103C126322002 @default.
• W2263402103 hasConceptScore W2263402103C141071460 @default.
• W2263402103 hasConceptScore W2263402103C2775872228 @default.
• W2263402103 hasConceptScore W2263402103C2778789114 @default.
• W2263402103 hasConceptScore W2263402103C2780176578 @default.
• W2263402103 hasConceptScore W2263402103C2780727368 @default.
• W2263402103 hasConceptScore W2263402103C3013748606 @default.
• W2263402103 hasConceptScore W2263402103C3019645122 @default.
• W2263402103 hasConceptScore W2263402103C512399662 @default.
• W2263402103 hasConceptScore W2263402103C71924100 @default.
• W2263402103 hasIssue "5" @default.
• W2263402103 hasLocation W22634021031 @default.
• W2263402103 hasLocation W22634021032 @default.
• W2263402103 hasLocation W22634021033 @default.
• W2263402103 hasLocation W22634021034 @default.
• W2263402103 hasOpenAccess W2263402103 @default.
• W2263402103 hasPrimaryLocation W22634021031 @default.
• W2263402103 hasRelatedWork W105067982 @default.
• W2263402103 hasRelatedWork W1575106205 @default.
• W2263402103 hasRelatedWork W1975930915 @default.
• W2263402103 hasRelatedWork W2002787743 @default.
• W2263402103 hasRelatedWork W2064276855 @default.
• W2263402103 hasRelatedWork W2098103967 @default.
• W2263402103 hasRelatedWork W2418059528 @default.
• W2263402103 hasRelatedWork W2915483679 @default.
• W2263402103 hasRelatedWork W2997390608 @default.
• W2263402103 hasRelatedWork W18685692 @default.
• W2263402103 hasVolume "22" @default.
• W2263402103 isParatext "false" @default.
• W2263402103 isRetracted "false" @default.

• next